---
schema_version: "secwatch.filing_event.v1"
accession: "0001601485-24-000013"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2024-02-02T23:59:59+00:00"
generated_at: "2026-06-06T09:56:10.915263+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Elicio raises CEO/CSO base pay, grants 225k/30k stock options, adopts severance plan

## Summary
- CEO base salary raised to $608,400; annual performance bonus opportunity set at 55% of base.
- CSO base salary increased to $460,000; annual performance bonus opportunity set at 40% of base.
- Stock options granted: 225,137 shares to CEO, 29,800 shares to CSO; vest 25% on first anniversary then monthly.
- New Executive Severance Plan provides salary-based multipliers for normal and change-in-control severance, plus equity acceleration.
- Severance benefits require a release and are conditioned on compliance with restrictive covenants.

## SEC filing metadata
- accession: 0001601485-24-000013
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2024-02-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000013/0001601485-24-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000013/angn-20240201.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601485-24-000013
- JSON: https://secwatch.observer/filing/0001601485-24-000013.json
- Plain text: https://secwatch.observer/filing/0001601485-24-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.